WO1998024896A3 - Muteines de la proteine de l'obesite - Google Patents

Muteines de la proteine de l'obesite Download PDF

Info

Publication number
WO1998024896A3
WO1998024896A3 PCT/EP1997/006541 EP9706541W WO9824896A3 WO 1998024896 A3 WO1998024896 A3 WO 1998024896A3 EP 9706541 W EP9706541 W EP 9706541W WO 9824896 A3 WO9824896 A3 WO 9824896A3
Authority
WO
WIPO (PCT)
Prior art keywords
muteins
obese protein
obese
protein
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1997/006541
Other languages
English (en)
Other versions
WO1998024896A2 (fr
Inventor
Rene Devos
Yves Guisez
Geert Plaetinck
Der Heyden Jose Van
Sandra Verploegen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to AU56549/98A priority Critical patent/AU5654998A/en
Publication of WO1998024896A2 publication Critical patent/WO1998024896A2/fr
Publication of WO1998024896A3 publication Critical patent/WO1998024896A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne les mutéines ob, les séquences d'ADN codant ces mutéines ob et des procédés de fabrication de ces dernières.
PCT/EP1997/006541 1996-12-06 1997-11-22 Muteines de la proteine de l'obesite Ceased WO1998024896A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU56549/98A AU5654998A (en) 1996-12-06 1997-11-22 Muteins of obese protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96119606 1996-12-06
EP96119606.0 1996-12-06

Publications (2)

Publication Number Publication Date
WO1998024896A2 WO1998024896A2 (fr) 1998-06-11
WO1998024896A3 true WO1998024896A3 (fr) 1998-10-01

Family

ID=8223476

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/006541 Ceased WO1998024896A2 (fr) 1996-12-06 1997-11-22 Muteines de la proteine de l'obesite

Country Status (8)

Country Link
AR (1) AR010333A1 (fr)
AU (1) AU5654998A (fr)
CO (1) CO4930295A1 (fr)
HR (1) HRP970654A2 (fr)
MA (1) MA24411A1 (fr)
PE (1) PE20399A1 (fr)
WO (1) WO1998024896A2 (fr)
ZA (1) ZA9710832B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US6420339B1 (en) * 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US8227408B2 (en) 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
AU2009248914A1 (en) 2008-05-21 2009-11-26 Neurotez, Inc. Methods for Treating Neurodegenerative Disorders Related to Neurofibrillary Tangles
CN102300581B (zh) 2008-11-04 2016-12-21 尼古拉斯·泰萨普塞蒂斯 用于治疗因神经原纤维缠结和β淀粉状蛋白的积聚引起的进行性认知功能障碍的瘦蛋白组合物和方法
WO2012050930A2 (fr) 2010-09-28 2012-04-19 Amylin Pharmaceuticals, Inc Polypeptides techniques de durée d'action supérieure

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137234A2 (fr) * 1983-08-17 1985-04-17 The Wellcome Foundation Limited Compositions physiologiquement actives
GB2292382A (en) * 1994-08-17 1996-02-21 Univ Rockefeller Obesity(OB) polypeptides
EP0725078A1 (fr) * 1995-01-31 1996-08-07 Eli Lilly And Company Protéines contre obesité
WO1996034885A2 (fr) * 1995-05-05 1996-11-07 Smithkline Beecham Plc Fragments peptidiques biologiquement actifs de proteines ob

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137234A2 (fr) * 1983-08-17 1985-04-17 The Wellcome Foundation Limited Compositions physiologiquement actives
GB2292382A (en) * 1994-08-17 1996-02-21 Univ Rockefeller Obesity(OB) polypeptides
EP0725078A1 (fr) * 1995-01-31 1996-08-07 Eli Lilly And Company Protéines contre obesité
WO1996034885A2 (fr) * 1995-05-05 1996-11-07 Smithkline Beecham Plc Fragments peptidiques biologiquement actifs de proteines ob

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VERPLOEGEN, S.A.B.W. ET AL.: "A human leptin mutant induces weight gain in normal mice.", FEBS LETTERS, vol. 405, no. 2, 24 March 1997 (1997-03-24), pages 237 - 240, XP002062174 *

Also Published As

Publication number Publication date
PE20399A1 (es) 1999-03-05
CO4930295A1 (es) 2000-06-27
ZA9710832B (en) 1998-06-08
MA24411A1 (fr) 1998-07-01
WO1998024896A2 (fr) 1998-06-11
AR010333A1 (es) 2000-06-07
HRP970654A2 (en) 1998-10-31
AU5654998A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
CA2258502A1 (fr) Facteur viii modifie
EP2290079A3 (fr) Facteurs neurotrophiques
WO2000040614A3 (fr) Caracterisation d'une famille de canaux calciques
CA2296769A1 (fr) Facteur modifie affectant le tissu dorsal et composition a base de ce facteur
WO1997007198A3 (fr) Sequences d'adn et proteines secretees codees par celles-ci
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
CA2232242A1 (fr) Proteines fluorescentes manipulees a grande longueur d'onde
WO2000018914A3 (fr) NOUVEAUX POLYPEPTIDES $i(DKR)
WO1994005791A3 (fr) Facteur influant sur la croissance du tissu dorsal et compositions
ZA9710288B (en) Novel genes encoding telomerase proteins.
AU2462399A (en) Cubilin protein, dna sequences encoding cubilin and uses thereof
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
WO1998024896A3 (fr) Muteines de la proteine de l'obesite
AU3711597A (en) A novel galanin receptor
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU3651597A (en) Dna sequences encoding human tcak1 kinase
WO2001053453A3 (fr) Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
WO1999035263A3 (fr) Adn codant il-17rh et polypeptides il-17rh
WO1996005300A3 (fr) Or-1 sur recepteur orphelin appartenant a la famille des recepteurs nucleaires
AU3138097A (en) Human calcium sensor protein, fragments thereof and dna encoding same
WO1998017827A3 (fr) Compositions et procedes utilisant la proteine eucaryote rad52
WO1997029194A3 (fr) Preparation d'acide l-ascorbique
EP0816498A3 (fr) Récepteur pour acide aminé excitateur et acides nucléiques liés
AU6844596A (en) Nucleotide sequence encoding the cd33-like protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN CZ HU ID IL JP KR LT LV MX NO NZ PL RO RU SG SI TR YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase